688535 华海诚科
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.6201.5103.8784.50011.412
总资产报酬率 ROA (%)0.4351.0633.0433.6458.228
投入资产回报率 ROIC (%)0.4781.1753.4394.33811.392

边际利润分析
销售毛利率 (%)28.57826.65625.63426.88027.007
营业利润率 (%)6.1864.53612.19111.04113.715
息税前利润/营业总收入 (%)7.8345.94713.77011.98314.260
净利润/营业总收入 (%)6.0555.24312.04211.18413.596

收益指标分析
经营活动净收益/利润总额(%)56.682-59.55529.26046.38884.973
价值变动净收益/利润总额(%)19.728123.19145.93141.1813.729
营业外收支净额/利润总额(%)-0.248-3.5917.7127.5521.184

偿债能力分析
流动比率 (X)3.6884.3641.8741.8592.981
速动比率 (X)3.0213.8391.4431.3962.409
资产负债率 (%)28.60931.17125.90116.51425.089
带息债务/全部投入资本 (%)18.71621.90514.5161.983-2.802
股东权益/带息债务 (%)420.577344.959572.5234,797.307-3,568.677
股东权益/负债合计 (%)249.536220.807286.010505.565298.585
利息保障倍数 (X)4.7093.79424.602299.69637.429

营运能力分析
应收账款周转天数 (天)126.688175.587137.360151.918136.758
存货周转天数 (天)103.518139.644118.638127.137110.099